Health

By the Retiree Report Editorial Team · Updated 2026-05-14 · 7 min read

This article is general information, not medical advice. Talk with a licensed clinician before making any decision about your care.

Shingrix after 50: why a third of older adults skip the shingles shot

About one in three Americans will develop shingles at some point, and the odds climb sharply after age 50. Two doses of Shingrix, the recombinant zoster vaccine, are more than 90% effective at preventing it — and since January 2023, they’ve been free for almost everyone on Medicare. Yet older-adult uptake still hovers around a third, well behind flu and pneumonia shots. This is what the numbers, the side effects, and the Medicare fine print actually say.

What shingles is, and why age matters

Shingles is the same virus that gave you chickenpox decades ago. After the initial infection clears, varicella-zoster lingers in the nerve roots and can reactivate years later as a painful, banded rash on one side of the body. According to the Centers for Disease Control and Prevention, about one in three people in the United States will have shingles in their lifetime, and roughly one million cases occur each year.

The risk curve is the part most adults underestimate. Most shingles cases happen after age 50, and incidence keeps climbing through the 60s, 70s, and 80s as the immune system’s grip on dormant viruses loosens. The disease itself is unpleasant — burning, stinging, blistering skin for a couple of weeks — but the bigger reason clinicians push the vaccine is what can come after.

The most common serious complication is postherpetic neuralgia, or PHN: nerve pain that lingers after the rash heals. Mayo Clinic describes PHN as a burning, stabbing pain that can last months or years, sometimes severe enough to disrupt sleep, work, and basic touch. Age is the dominant risk factor. PHN is unusual in healthy adults under 40 and increasingly common past 60, and it’s notoriously hard to treat once it sets in.

How well Shingrix actually works

Shingrix is a two-dose, non-live recombinant vaccine. The CDC recommends it for all immunocompetent adults aged 50 and older, with the two doses given between two and six months apart. Adults 19 and older with weakened immune systems are also eligible, and the CDC’s vaccine guidance notes there is no maximum age — an 85-year-old can still benefit.

The effectiveness numbers are what set Shingrix apart from the older Zostavax shot, which was pulled from the U.S. market in 2020. In clinical trials, Shingrix was about 97% effective at preventing shingles in adults aged 50 to 69 with healthy immune systems, and roughly 91% effective in those 70 and older. Protection appears to remain strong for at least seven years after the second dose; CDC is continuing to track longer-term durability.

That efficacy holds even if you’ve already had shingles, and even if you got the older Zostavax shot years ago. The CDC explicitly recommends Shingrix in both situations, and routine testing for past chickenpox is not required before vaccination. If you’re not sure whether you had chickenpox as a child, you almost certainly were exposed: more than 99% of Americans born before 1980 carry the virus, vaccinated or not.

What you’ll pay on Medicare in 2026

This is where the math has changed most dramatically. Before 2023, Shingrix sat under Medicare Part D rather than Part B, which meant beneficiaries often paid a copay or hit a deductible — sometimes $150 to $200 for the two-dose series, depending on the plan. The Inflation Reduction Act rewrote that rule.

Since January 1, 2023, every Part D plan and every Medicare Advantage plan that includes drug coverage must cover all vaccines recommended by the CDC’s Advisory Committee on Immunization Practices at zero cost-sharing. According to Medicare.gov’s coverage page, that includes Shingrix: no copay, no deductible, no coinsurance. The Centers for Medicare & Medicaid Services reported that roughly 3.9 million Medicare enrollees received a shingles vaccine in 2023, a more than 40% jump from 2021, the last year before the rule changed.

A few practical wrinkles still trip people up. If you don’t have Part D or a Medicare Advantage plan with drug coverage, you’ll pay full price — typically around $200 per dose at retail pharmacies. If your plan is administered through a pharmacy benefit manager, the shot is usually billed at the pharmacy, not the doctor’s office; some primary care clinics aren’t set up to bill Part D directly, which means you may need to schedule the vaccine at a chain pharmacy instead. The AARP recommends asking specifically whether the location bills Part D before you sit down for the shot. If you’re still comparing drug plans, our Medicare open enrollment 2026 checklist walks through how to confirm vaccine coverage in a specific Part D formulary.

The side effect nobody warns you about

The biggest practical complaint about Shingrix isn’t safety — it’s that the second dose, in particular, often knocks people sideways for a day or two. The vaccine is designed to provoke a strong immune response, and that response shows up.

In the clinical trials the CDC cites, about 78% of recipients reported some pain at the injection site, and roughly one in ten experienced a severe enough reaction — fatigue, muscle aches, headache, fever, chills — to interfere with normal activities for a day. These symptoms typically resolve within two to three days. The CDC and FDA still recommend completing the second dose even if the first reaction was uncomfortable, because protection from a single dose drops off meaningfully over time.

The practical takeaway is to schedule strategically. Don’t book the second dose the day before a flight, a wedding, or a workday you can’t afford to miss. Pick a Friday afternoon, plan for a quiet Saturday, and have acetaminophen or ibuprofen on hand. Severe allergic reactions are rare; the main published contraindication is a documented severe allergic reaction to a prior dose or to a component of the vaccine. If you have an active shingles outbreak right now, the CDC says to wait until the rash has resolved before vaccinating.

Where uptake stalls, and how to actually get the shot

Despite the price drop, vaccination rates remain stubborn. CDC’s National Center for Health Statistics found that shingles vaccination among adults 60 and older rose from 6.7% in 2008 to 34.5% in 2018, with more recent estimates around 40%. That means roughly six out of ten older adults — and a larger share of Black and Hispanic adults, where the gap has been about 20 percentage points — still haven’t received any shingles vaccine. Cost was a real barrier before 2023; since then, the bigger drivers appear to be lack of a clinician recommendation, confusion about whether a past Zostavax shot still counts, and worry about side effects.

If you want to act on this, the path is short. Call your primary care office and ask whether they administer Shingrix in-house and bill Part D, or whether you’ll be sent to a pharmacy. CVS, Walgreens, Walmart, Costco, and most independent pharmacies stock it and can usually run the Part D claim while you wait. Bring your Medicare card and your Part D or Medicare Advantage card; the pharmacy needs both. Once you’ve had the first dose, put the second on the calendar two to six months out — don’t drift past six months, since the CDC’s recommendation is built around that window.

This is not medical advice for any individual situation. If you’re immunocompromised, pregnant, currently being treated for shingles, or have a history of severe allergic reaction to a vaccine, talk with your doctor before scheduling. And if you’re sorting out how vaccines fit into broader drug coverage, our explainer on the Medicare Part D 2026 out-of-pocket cap covers the other big change beneficiaries should know.

What to remember

The case for Shingrix after 50 is unusually strong: a vaccine that’s more than 90% effective, recommended by the CDC, and free under almost every Medicare drug plan since 2023. The main reason to plan around it is reactogenicity — the second dose can wipe out a day or two — not safety. If you’ve been putting it off because of cost or confusion about the old Zostavax shot, neither reason still applies; the harder part now is just making the two appointments.